Toxicity /

Testing drug safety and potential

to eliminate toxicity and promote more rational drug design

 

Clinical Trials   Good Manufacturing Practice

Start   /   Toxicity

Testing drug safety and potential

We develop preclinical models to determine the toxic effects of potential drugs and their metabolism.

Toxicity is one of the most common reasons for manufacturers to withdraw drugs and for health organisations to refuse the approval of new drugs. Sometimes as many as one-third of all drugs fail clinical trials because of toxicity. Current toxicity tests are complicated and some even use chemicals that kill the cells, so that researchers have to use a number of different cell cultures during a study, which affects the result. Another challenge is that although traditional animal and cell models stimulate human disease, they never fully mirror all aspects of human immune response. That is why new, more clinically relevant models have to be created to properly assess the safety and risks of potential drugs for humans.

 

Information

Good Manufacturing Practice ››

About us

News
People
How to find us
Contact us

 

Research

Chondrocytes
Gene editing
Hepatocytes
Pancreatic cells
Skin cells

 

         

 

© 2019 Nordic Joincells AB | This site uses cookies